HALO Stock Analysis: Buy, Sell, or Hold?
HALO - Halozyme Therapeutics, Inc.
$69.21
-0.82 (-1.17%)
▼
5d:
+6.17%
30d:
+1.7%
90d:
-10.02%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
HALO is down 4.4% this week, but smart money is accumulating calls. Top strike: $70 2026-06-18 with 1,024 OI. Call ratio: 67% View Scanner →
Strength: 3.9/10
Get Alerted When HALO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called HALO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HALO shows positive signals but monitor for confirmation. Market pricing in 2.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: HALO shows positive signals but monitor for confirmation. Market pricing in 2.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$136.37
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$84.67
18.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HALO is currently trading at $69.21, which is considered extended relative to its 30-day fair value range of $64.19 to $68.59. The stock's valuation (Forward PE: 7.0) is in line with its historical norms (7.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.9% over the next few years. This pessimistic expectation contrasts with the company's recent 31.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HALO is in a strong uptrend. Immediate support is located at $62.38, while resistance sits at $73.89.
Market Sentiment: HALO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $85.44 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HALO is in a strong uptrend. Immediate support is located at $62.38, while resistance sits at $73.89.
Market Sentiment: HALO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $85.44 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$64.19 -
$68.59
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.5% below Wall St target ($85.44)
Trading Range Analysis
30-Day Trading Range
$64.19 -
$68.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$62.38
Resistance Level
$73.89
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.04
Wall Street Target
$85.44
(+23.5%)
Revenue Growth (YoY)
42.2%
Earnings Growth (YoY)
31.2%
Profit Margin
23.1%
Valuation Discount vs History
-2.9% cheaper
PE vs Historical
7.0 vs 7.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.9%
(market-implied from PE analysis)
1-Year Target
$67.20
(-3%)
2-Year Target
$65.25
(-6%)
3-Year Target
$63.36
(-9%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$69.33
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 21.3%)
$386.87
(+459%)
Base:
(SPY PE: 7.0, Growth: 21.3%)
$123.52
(+79%)
Bear:
(PE: 6.0, Growth: 21.3%)
$105.00
(+52%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 24.57 | Current EPS (TTM): $2.85
Bull Case
$154.07
(+123%)
Analyst growth 100.0%, PE expands to 27.0
Base Case
$140.06
(+102%)
Market implied 100.0%, PE stable at 24.6
Bear Case
$47.62
(-31%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.0 to 7.7
Stabilization Target:
$75.73
(+9.4%)
PE Expansion Potential:
+9.4%
Share & Embed Analysis
Last updated: May 14, 2026 10:51 PM ET
Data refreshes hourly during market hours. Next update: 11:51 PM
Data refreshes hourly during market hours. Next update: 11:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HALO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Helen Torley
SELL
10000 shares
2026-04-06
Helen Torley
SELL
20000 shares
2026-04-02
Cortney Caudill
SELL
8857 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 49 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 55 HOLD |
Advanced HALO Option Strategies
Professional options setups generated by AI based on today's HALO price and gamma walls.
